H. Tsunoda

Pharmacogenomics and therapeutic target validation in cerebral vasospasm.

Y. Nishimura, M. Naka, T. Tanaka, 2000, Journal of cardiovascular pharmacology.

Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm.

Y. Shimada, Toshio Tanaka, Liqing Zang, 2009, European journal of pharmacology.

Potential Role for Heat Shock Protein 72 in Antagonizing Cerebral Vasospasm After Rat Subarachnoid Hemorrhage

Y. Nishimura, T. Kirino, Toshio Tanaka, 2004, Circulation.

The functional significance of heme oxygenase-1 gene induction in a rat vasospasm model.

K. Kanamaru, H. Suzuki, S. Waga, 2001, Acta neurochirurgica. Supplement.

[Pharmacogenomics and pharmainformatics].

Y. Nishimura, M. Naka, Toshio Tanaka, 2002, Nihon rinsho. Japanese journal of clinical medicine.

Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats.

K. Kanamaru, H. Suzuki, H. Inada, 1999, The Journal of clinical investigation.

Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm.

Toshio Tanaka, Liqing Zang, H. Tsunoda, 2009, European journal of pharmacology.

Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase.

K. Matsushima, Y. Kawarada, T. Tanaka, 1998, Biochemical and biophysical research communications.